These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12360423)

  • 1. Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: potential therapeutic targets.
    Sirica AE; Lai GH; Endo K; Zhang Z; Yoon BI
    Semin Liver Dis; 2002 Aug; 22(3):303-13. PubMed ID: 12360423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions.
    Endo K; Yoon BI; Pairojkul C; Demetris AJ; Sirica AE
    Hepatology; 2002 Aug; 36(2):439-50. PubMed ID: 12143054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. erbB-2/neu transformed rat cholangiocytes recapitulate key cellular and molecular features of human bile duct cancer.
    Lai GH; Zhang Z; Shen XN; Ward DJ; Dewitt JL; Holt SE; Rozich RA; Hixson DC; Sirica AE
    Gastroenterology; 2005 Dec; 129(6):2047-57. PubMed ID: 16344070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclooxygenase-1 and -2 in extra-hepatic cholangiocarcinoma.
    Wu GS; Wang JH; Liu ZR; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):429-33. PubMed ID: 14607721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of c-erbB-2 and cyclooxygenase-2 in intrahepatic cholangiocarcinoma.
    Choi HJ; Kim HJ; Choi JH
    Hepatogastroenterology; 2009; 56(91-92):606-9. PubMed ID: 19621664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinoma.
    Schmitz KJ; Lang H; Wohlschlaeger J; Reis H; Sotiropoulos GC; Schmid KW; Baba HA
    Virchows Arch; 2007 Feb; 450(2):135-41. PubMed ID: 17165088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic bile duct injury associated with fibrotic matrix microenvironment provokes cholangiocarcinoma in p53-deficient mice.
    Farazi PA; Zeisberg M; Glickman J; Zhang Y; Kalluri R; DePinho RA
    Cancer Res; 2006 Jul; 66(13):6622-7. PubMed ID: 16818635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma.
    Chariyalertsak S; Sirikulchayanonta V; Mayer D; Kopp-Schneider A; Fürstenberger G; Marks F; Müller-Decker K
    Gut; 2001 Jan; 48(1):80-6. PubMed ID: 11115827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2, c-KIT and HER-2/neu expression in uterine carcinosarcomas: prognostic factors or potential markers for targeted therapies?
    Raspollini MR; Susini T; Amunni G; Paglierani M; Taddei A; Marchionni M; Scarselli G; Taddei GL
    Gynecol Oncol; 2005 Jan; 96(1):159-67. PubMed ID: 15589595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclooxygenase-2 in cholangiocarcinoma: correlation with clinicopathological features and prognosis.
    Kim HJ; Lee KT; Kim EK; Sohn TS; Heo JS; Choi SH; Choi DI; Lee JK; Paik SW; Rhee JC
    J Gastroenterol Hepatol; 2004 May; 19(5):582-8. PubMed ID: 15086604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy.
    Sirica AE
    Hepatology; 2005 Jan; 41(1):5-15. PubMed ID: 15690474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression of cyclooxygenase-2 in biliary epithelia of bile duct cancer with or without pancreaticobiliary maljunction.
    Watanabe O; Yoshimatsu K; Shiozawa S; Tsuchiya A; Oshibe N; Aiba M; Ogawa K
    Anticancer Res; 2004; 24(2B):671-4. PubMed ID: 15161010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary cancer growth factor pathways, cyclo-oxygenase-2 and potential therapeutic strategies.
    Sirica AE; Lai GH; Zhang Z
    J Gastroenterol Hepatol; 2001 Apr; 16(4):363-72. PubMed ID: 11357901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2.
    Wang SC; Lien HC; Xia W; Chen IF; Lo HW; Wang Z; Ali-Seyed M; Lee DF; Bartholomeusz G; Ou-Yang F; Giri DK; Hung MC
    Cancer Cell; 2004 Sep; 6(3):251-61. PubMed ID: 15380516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt expression may predict favorable prognosis in cholangiocarcinoma.
    Javle MM; Yu J; Khoury T; Chadha KS; Iyer RV; Foster J; Kuvshinoff BW; Gibbs JF; Geradts J; Black JD; Brattain MG
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1744-51. PubMed ID: 16984600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer.
    Ranger GS; Thomas V; Jewell A; Mokbel K
    Anticancer Res; 2004; 24(4):2349-51. PubMed ID: 15330183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays.
    Kim JY; Lim SJ; Park K; Lee CM; Kim J
    Gynecol Oncol; 2005 May; 97(2):337-41. PubMed ID: 15863127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide induced cell death in human osteoarthritic synoviocytes is mediated by tyrosine kinase activation and hydrogen peroxide and/or superoxide formation.
    Jovanovic DV; Mineau F; Notoya K; Reboul P; Martel-Pelletier J; Pelletier JP
    J Rheumatol; 2002 Oct; 29(10):2165-75. PubMed ID: 12375328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fascin overexpression is involved in carcinogenesis and prognosis of human intrahepatic cholangiocarcinoma: immunohistochemical and molecular analysis.
    Iguchi T; Aishima S; Taketomi A; Nishihara Y; Fujita N; Sanefuji K; Sugimachi K; Yamashita Y; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2009 Feb; 40(2):174-80. PubMed ID: 18835624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.